Results 131 to 140 of about 27,110,461 (296)
A Two‐Stage Plasma Biomarker Algorithm Reduces Amyloid PET Use and the p‐Tau217 Gray Zone
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Plasma p‐Tau217 leaves 30%–50% of patients in an indeterminate “gray zone” often requiring Aβ‐PET. We developed GRAD (Gatekeeper‐Reflex for Alzheimer's Disease), a two‐stage Aβ‐positivity prediction model to improve classification while reserving Aβ‐PET for residual uncertainty.
Harthik Parankusham +7 more
wiley +1 more source
Cost-Benefit Analysis in a Framework of Stakeholder Involvement and Integrated Coastal Zone Modeling [PDF]
Active involvement of local stakeholders is currently an increasingly important requirement in European environmental regulations such as the EU Water Framework Directive (WFD) and the EU Marine Strategy Framework Directive (MSFD).
Söderqvist, Tore +4 more
core
Benefit-Cost Analysis in Public Health
, 1996 This chapter gives an overview of benefit-cost analysis (BCA) and similar evaluation tools, such as cost-effectiveness analysis and technology-based standards, in the context of public health.
Lester B Lave (5455793) +1 more
core +1 more source
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Background Blood‐based biomarkers are increasingly used to identify Alzheimer's disease (AD) pathology and may play an important role in early disease screening and participant selection for clinical trials. However, their performance across stages of cognitive impairment remains unclear. This study examined whether plasma biomarkers differ in
Maryam Abdolmaleki +7 more
wiley +1 more source
An Aggregate Measure for Benefit-Cost Analysis [PDF]
The Kaldor-Hicks (KH) criterion has long been the standard for benefit-cost analysis, but it has also been widely criticized for ignoring equity and, arguably, moral sentiments in general.
Finkle, Aaron +2 more
core
Renewable energy cost-benefit analysis under Malaysian feed-in-tariff
, 2012 Penetration of renewable energy sources in Europe have increased significantly for the past 10 years, especially in Germany. One important factor contributing to this improvement is the introduction of Feed-in Tariff (FiT).
Abdullah, A. S. +7 more
core +1 more source
Arthritis Care &Research, EarlyView.Systemic sclerosis (SSc) is a rare autoimmune disease defined by immune dysregulation, vasculopathy, and progressive fibrosis of the skin and internal organs. Despite advances in care, major complications such as interstitial lung disease (ILD) and myocardial involvement remain the leading causes of morbidity and mortality.
Cristiana Sieiro Santos +2 more
wiley +1 more source
International Scientific Journal of Engineering and ManagementThe cost benefit analysis helps in finding out the relationship of costs and revenues to output. It enables the financial manager to study the general effect of the level of output upon income and expenses and therefore upon profits. Cost-Benefit Analysis (CBA) estimates and totals up the equivalent money value of the benefits and costs to the ...
+6 more sources
Identifying an Australian ‘Shadow’ Benefit / Cost Ratio for Public Projects [PDF]
This paper examines the social opportunity cost of a hypothetical public project in Australia and compares these values with the cost of the project as measured by factor prices.
Lawrence, Craig
core +2 more sources
Do the selected Trans European transport investments pass the Cost Benefit test? [PDF]
This paper assesses the economic justification for the selection of priority projects defined under the auspices of the Trans-European transport network.
Artem KORZHENEVYCH +5 more
core